Ossification, Heterotopic
"Ossification, Heterotopic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The development of bony substance in normally soft structures.
| Descriptor ID |
D009999
|
| MeSH Number(s) |
C23.550.751
|
| Concept/Terms |
Ossification, Heterotopic- Ossification, Heterotopic
- Ossification, Pathologic
- Ectopic Ossification
- Pathologic Ossification
- Heterotopic Ossification
- Ossification, Ectopic
- Ossification, Pathological
- Pathological Ossification
|
Below are MeSH descriptors whose meaning is more general than "Ossification, Heterotopic".
Below are MeSH descriptors whose meaning is more specific than "Ossification, Heterotopic".
This graph shows the total number of publications written about "Ossification, Heterotopic" by people in this website by year, and whether "Ossification, Heterotopic" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 1 | 3 |
| 1999 | 1 | 0 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 2 | 4 |
| 2005 | 1 | 1 | 2 |
| 2006 | 4 | 1 | 5 |
| 2008 | 2 | 3 | 5 |
| 2009 | 3 | 2 | 5 |
| 2010 | 4 | 2 | 6 |
| 2011 | 3 | 2 | 5 |
| 2012 | 4 | 2 | 6 |
| 2013 | 2 | 2 | 4 |
| 2014 | 6 | 0 | 6 |
| 2015 | 2 | 1 | 3 |
| 2016 | 4 | 2 | 6 |
| 2017 | 7 | 4 | 11 |
| 2018 | 3 | 2 | 5 |
| 2019 | 3 | 2 | 5 |
| 2020 | 7 | 0 | 7 |
| 2021 | 6 | 4 | 10 |
| 2022 | 12 | 0 | 12 |
| 2023 | 6 | 0 | 6 |
| 2024 | 4 | 2 | 6 |
| 2025 | 0 | 1 | 1 |
Below are the most recent publications written about "Ossification, Heterotopic" by people in Profiles.
-
Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin-/-/Utrophin-/- Double-Knockout Mice. Cells. 2025 Jan 14; 14(2).
-
Long-term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva. Rheumatology (Oxford). 2024 09 01; 63(9):2597-2604.
-
Miliary osteoma cutis in a climbing mantella frog (Mantella laevigata). Vet Dermatol. 2024 Oct; 35(5):582-585.
-
Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice. J Bone Miner Res. 2024 May 02; 39(4):382-398.
-
Immunologic Aspects in Fibrodysplasia Ossificans Progressiva. Biomolecules. 2024 Mar 16; 14(3).
-
Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification. Biomolecules. 2024 Mar 14; 14(3).
-
Physical and psychosocial outcomes among burn-injured people with heterotopic ossification: A burn model system study. Burns. 2024 05; 50(4):957-965.
-
Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva. BMC Med Res Methodol. 2023 11 13; 23(1):269.
-
Most Fractures Treated Nonoperatively in Individuals With Fibrodysplasia Ossificans Progressiva Heal With a Paucity of Flareups, Heterotopic Ossification, and Loss of Mobility. Clin Orthop Relat Res. 2023 12 01; 481(12):2447-2458.
-
Predictors of Adverse Events in the Surgical Treatment of Adult Distal Humerus Fractures. Orthopedics. 2023 Nov-Dec; 46(6):352-357.